Intrinsic Value

PHRRF doesn't have a meaningful market cap.

The intrinsic value of Pharmather Holdings Ltd (PHRRF) under the Base Case is 0.03 USD per share. Compared with the current market price of 0.03 USD, the stock appears Overvalued by 13% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

PHRRF Intrinsic Value
$0.03
Overvaluation 13%
Intrinsic Value
Price $0.03

PHRRF is cheaper than usual. Still overvalued, but less so than on 85% of days in the past 5 years.

Alert me when PHRRF is below its intrinsic value
Today $0.02 · 30.1% below the current price
Alternatives to PHRRF

Fundamental Analysis

What Pharmather Does

PharmaTher Holdings Ltd. is a specialty psychedelic pharmaceutical company, which engages in the research, development and commercialization of ketamine and novel microneedle patches for delivering psychedelics to treat neuropsychiatric, neurodegenerative, and pain disorders. The company is headquartered in Toronto, Ontario. The company went IPO on 2020-10-09. The firm develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes.

Headquarters
Canada CA
IPO date
Oct 9, 2020
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue PHRRF Research

Decided on Pharmather? Get an email when PHRRF reaches the price you’d buy at. Free with an account.

Other Pharmather listings

What is the Intrinsic Value of one PHRRF stock?

The intrinsic value for Pharmather Holdings Ltd (PHRRF) under the Base Case is 0.03 USD.

Is PHRRF stock undervalued or overvalued?

Compared with the current market price of 0.03 USD, the stock appears Overvalued by 13% .

How reliable are our estimates? See how past valuations played out
Back to Top